17β-estradiol decreases vulnerability to ventricular arrhythmias by preserving Connexin43 protein in infarcted rats

European Journal of Pharmacology

Volumn 629, Issue 1-3, 2010, Pages 73-81

  Chen, Chien Chang ^a   Lin, Chih Chan ^a   Lee, Tsung Ming ^b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arrhythmias; Connexin43; Echocardiogram; Estradiol; Myocardial infarction

Indexed keywords

CONNEXIN 43; ESTRADIOL; ESTROGEN RECEPTOR; GAP JUNCTION PROTEIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PLACEBO; TAMOXIFEN; ESTROGEN; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ELECTROSTIMULATION; FEMALE; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE ARRHYTHMIA; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS WEIGHT; WESTERN BLOTTING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION; HEART ARRHYTHMIA; HEART VENTRICLE; HEMODYNAMICS; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; UTERUS; WISTAR RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; BODY WEIGHT; CONNEXIN 43; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGICAL PROCESSES; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HEART VENTRICLES; HEMODYNAMICS; MYOCARDIAL INFARCTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORGAN SIZE; RATS; RATS, WISTAR; UTERUS;

EID: 74149089676     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.050     Document Type: Article

References (39)

1. Beer S., Reincke M., Kral M., Callies F., Strömer H., Dienesch C., Steinhauer S., Ertl G., Allolio B., and Neubauer S. High-dose 17beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat. Basic Res. Cardiol. 102 (2007) 9-18
2. Bélichard P., Savard P., Cardinal R., Nadeau R., Gosselin H., Paradis P., and Rouleau J.L. Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J. Am. Coll. Cardiol. 23 (1994) 505-513
3. Bennett M.V.L., Barrio L.C., Bargiello T.A., Spray D.C., Hertzberg E.L., and Saez J.C. Gap junction: new tools, new answers, new questions. Neuron 6 (1991) 305-320
4. Beyer E.C., Paul D.L., and Goodenough D.A. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J. Cell Biol. 105 (1987) 2621-2629
5. Chung T.H., Wang S.M., and Wu J.C. 17beta-estradiol reduces the effect of metabolic inhibition on gap junction intercellular communication in rat cardiomyocytes via the estrogen receptor. J. Mol. Cell. Cardiol. 37 (2004) 1013-1022
6. Formigli L., Ibba-Manneschi L., Perna A.M., Pacini A., Polidori L., Nediani C., Modesti P.A., Nosi D., Tani A., Celli A., Neri-Serneri G.G., Quercioli F., and Zecchi-Orlandini S. Altered Cx43 expression during myocardial adaptation to acute and chronic volume overloading. Histol. Histopathol. 18 (2003) 359-369
7. Genade S., Genis A., Ytrehus K., Huisamen B., and Lochner A. Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. J. Pineal Res. 45 (2008) 449-458
8. Goodenough D.A., Goliger J.A., and Paul D.L. Connexin, connexons and intercellular communication. Ann. Rev. Biochem. 65 (1996) 475-502
9. Gutstein D.E., Morley G.E., Tamaddon H., Vaidya D., Schneider M.D., Chen J., Chien K.R., Stuhlmann H., and Fishman G.I. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ. Res. 88 (2001) 333-339
10. Hamid S.A., Bower H.S., and Baxter G.F. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. Am. J. Physiol. 292 (2007) H2598-H2606
11. + currents in rat ventricular myocytes. Am. J. Physiol. 285 (2003) H661-H668
12. Herre J.M., Wetstein L., Lin Y.L., Mills A.S., Dae M., and Thames M.D. Effect of transmural versus nontransmural myocardial infarction on inducibility of ventricular arrhythmias during sympathetic stimulation in dogs. J. Am. Coll. Cardiol. 11 (1988) 414-421
13. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., and Vittinghoff E. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613
14. Iwakura A., Shastry S., Luedemann C., Hamada H., Kawamoto A., Kishore R., Zhu Y., Qin G., Silver M., Thorne T., Eaton L., Masuda H., Asahara T., and Losordo D.W. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 113 (2006) 1605-1614
15. Kaprielian R.R., Gunning M., Dupont E., Sheppard M.N., Rothery S.M., Underwood R., Pennell D.J., Fox K., Pepper J., Poole-Wilson P.A., and Severs N.J. Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 97 (1998) 651-660
16. Kimura M., Irahara M., Yasui T., Saito S., Tezuka M., Yamano S., Kamada M., and Aono T. The obesity in bilateral ovariectomized rats is related to a decrease in the expression of leptin receptors in the brain. Biochem. Biophys. Res. Commun. 290 (2002) 1349-1353
17. Kitamura H., Ohnishi Y., Yoshida A., Okajima K., Azumi H., Ishida A., Galeano E.J., Kubo S., Hayashi Y., Itoh H., and Yokoyama M. Heterogeneous loss of connexin43 protein in nonischemic dilated cardiomyopathy with ventricular tachycardia. J. Cardiovasc. Electrophysiol. 13 (2002) 865-870
18. Korte T., Fuchs M., Arkudas A., Geertz S., Meyer R., Gardiwal A., Klein G., Niehaus M., Krust A., Chambon P., Drexler H., Fink K., and Grohé C. Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction. Circulation 111 (2005) 2282-2290
19. + channels in canine hearts. J. Mol. Cell. Cardiol. 32 (2000) 1147-1158
20. Lee T.M., Lin M.S., Chou T.F., Tsai C.H., and Chang N.C. Adjunctive 17β-estradiol administration reduces infarct size by altered expression of canine myocardial connexin43 protein. Cardiovasc. Res. 63 (2004) 109-117
21. Lee T.M., Lin M.S., and Chang N.C. Effect of ATP-sensitive potassium channel agonists on ventricular remodeling in healed rat infarcts. J. Am. Coll. Cardiol. 51 (2008) 1309-1318
22. Lee T.M., Lin M.S., and Chang N.C. Physiological concentration of 17beta-estradiol on sympathetic reinnervation in ovariectomized infarcted rats. Endocrinology 149 (2008) 1205-1213
23. Lefebvre D.L., Piersanti M., Bai X.H., Chen Z.Q., and Lye S.J. Myometrial transcriptional regulation of the gap junction gene, connexin-43. Reprod. Fertil. Dev. 7 (1995) 603-611
24. Liu M.Y., Hattori Y., Sato A., Ichikawa R., Zhang X.H., and Sakuma I. Ovariectomy attenuates hyperpolarization and relaxation mediated by endothelium-derived hyperpolarizing factor in female rat mesenteric artery: a concomitant decrease in connexin-43 expression. J. Cardiovasc. Pharmacol. 40 (2002) 938-948
25. Loyer X., Damy T., Chvojkova Z., Robidel E., Marotte F., Oliviero P., Heymes C., and Samuel J.L. 17beta-estradiol regulates constitutive nitric oxide synthase expression differentially in the myocardium in response to pressure overload. Endocrinology 148 (2007) 4579-4584
26. Manson J.E., Hsia J., Johnson K.C., Rossouw J.E., Assaf A.R., Lasser N.L., Trevisan M., Black H.R., Heckbert S.R., Detrano R., Strickland O.L., Wong N.D., Crouse J.R., Stein E., Cushman M., and Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349 (2003) 523-534
27. Nakajima T., Iwasawa K., Oonuma H., Morita T., Goto A., Wang Y., and Hazama H. Antiarrhythmic effect and its underlying ionic mechanism of 17beta-estradiol in cardiac myocytes. Br. J. Pharmacol. 127 (1999) 429-440
28. Nguyen T., El Salibi E., and Rouleau J.L. Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat: effects of ramipril and hydralazine. Circulation 98 (1998) 2074-2080
29. Pfeffer M.A., and Braunwald E. Ventricular remodeling after myocardial infarction. Circulation 81 (1990) 1161-1172
30. Ríos M., Hermoso M., Sánchez T.M., Croxatto H.B., and Villalón M.J. Effect of oestradiol and progesterone on the instant and directional velocity of microsphere movements in the rat oviduct: gap junctions mediate the kinetic effect of oestradiol. Reprod. Fertil. Dev. 19 (2007) 634-640
31. Rodriguez-Hernandez A., Rubio-Gayosso I., Ramirez I., Ita-Islas I., Meaney E., Gaxiola S., Meaney A., Asbun J., Figueroa-Valverde L., and Ceballos G. Intraluminal-restricted 17 beta-estradiol exerts the same myocardial protection against ischemia/reperfusion injury in vivo as free 17 beta-estradiol. Steroids 73 (2008) 528-538
32. Roell W., Lewalter T., Sasse P., Tallini Y.N., Choi B.R., Breitbach M., Doran R., Becher U.M., Hwang S.M., Bostani T., von Maltzahn J., Hofmann A., Reining S., Eiberger B., Gabris B., Pfeifer A., Welz A., Willecke K., Salama G., Schrickel J.W., Kotlikoff M.I., and Fleischmann B.K. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450 (2007) 817-824
33. Schatzkin A., Cupples A., Heeren T., Morelock S., and Kannel W.B. Sudden death in the Framingham heart study: differences in incidence and risk factors by sex and coronary status. Am. J. Epidemiol. 120 (1984) 888-899
34. Shlipak M.G., Angeja B.G., Go A.S., Frederick P.D., Canto J.G., and Grady D. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation 104 (2001) 2300-2304
35. Spinler S.A., Hilleman D.E., Cheng J.W., Howard P.A., Mauro V.F., Lopez L.M., Munger M.A., Gardner S.F., and Nappi J.M. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann. Pharmacother. 35 (2001) 589-617
36. Thorin E., Pham-Dang M., Clement R., Mercier I., and Calderone A. Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen. Br. J. Pharmacol. 140 (2003) 1187-1192
37. Verrecchia F., and Hervé J. Reversible inhibition of gap junctional communication by tamoxifen in cultured cardiac myocytes. Pflugers Arch. 434 (1997) 113-116
38. Weber K.T., Anversa P., Armstrong P.W., Brilla C.G., Burnett Jr. J.C., Cruickshank J.M., Devereux R.B., Giles T.D., Korsgaard N., and Leier C.V. Remodeling and reparation of the cardiovascular system. J. Am. Coll. Cardiol. 20 (1992) 3-16
39. Yao J., Hiramatsu N., Zhu Y., Morioka T., Takeda M., Oite T., and Kitamura M. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells. J. Am. Soc. Nephrol. 16 (2005) 58-67